HomeMiddle EastUAE eyes self sufficiency in production of generic drugs

UAE eyes self sufficiency in production of generic drugs

1481984634 108820316

The UAE is close to being self-sufficient in producing generic drugs as 16 pharmaceutical facilities are manufacturing up to 1,000 such drugs, according to a senior official from the Ministry of Health and Prevention.

ADVERTISEMENT

Dr Ameen Hussain Al Amiri, the Ministry’s Assistant Under-Secretary for Public Health and Licensing said in comments published by news agency WAM that the country is also planning to increase the number of manufacturing facilities to 30 by 2020.

This is another indication of the strong growth of the pharmaceutical industry and the efforts being exerted to improve the UAE’s global competitiveness, he said.

“The global biopharmaceutical market is huge as manufacturers are planning to produce biopharmaceuticals – biologic medications or biologics – using living organisms and DNA. Producing biologics is more expensive and more effective than generic drugs; however, biologics will remain less expensive,” added Al Ameri.

A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted from or semi-synthesised from biological sources.

Different from totally synthesised pharmaceuticals, these include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein and living cells used in cell therapy.

Source link

ADVERTISEMENT

ADVERTISEMENT
Just in:
Court Sides with Coinbase on Wallet Service, But Staking Program Remains in Limbo // Universal Language for Healthcare: General Authority Embraces Global Coding System // Ajman Celebrates Conclusion of Ramadan Activities with Grand Ceremony // AI Boost for Galaxy Devices: Samsung Expands One UI 6.1 Update // Konica Minolta is named ASEAN 2023 Market Leader in Colour Light and Mid Digital Production Printers // German Job Market Resilience Bodes Well for Economic Recovery // Emirati Aid Reaches Ukraine as Food Shortages Bite // No running of govt from jail, says Delhi Lt Governor // In Lok Sabha Polls In Punjab, AAP Is Advantageously Placed As Against Its Three Rivals // Arvind Kejriwal Was Used By BJP In 2011 Movement To Take On The Congress // Experts come together to support updating the city’s nature conservation masterplan // Renewables Surge Sets Record, But Global Equity Lags // U.S. Compliance Takes Center Stage at OKX Following Industry Jitters // Samsung Partners National Heritage Board to Bring a Slice of Singapore’s Cultural Heritage to Samsung The Frame TV // Ingdan Announces 2023 Annual Results // Superland Announced Annual Results for 2023, 2023 Net Profit Increased approximately 39.5% to approximately HK$22.2 million as Compared to the 2022 Adjusted One // Party Nominees Refusing To Contest: Major Perception Threat For BJP // US reiterates concern over Kejriwal arrest, Cong accounts // Meta Earth Official Website Launch: The Pioneer Explorer in the Modular Public Blockchain Domain // Global Audience to Witness Thrill of Dubai World Cup //